GlassScriptPhysician profile
Andrea Das
NPI 1477608743
$12,972.05
in general payments reported to CMS, 2019-2025
38 companies · $787 in 2025
The $787 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,620 · 2020: $350 · 2021: $743 · 2022: $1,899 · 2023: $793 · 2024: $781 · 2025: $787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,109 · Education: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,109.40 |
| Education | $251.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,817.01 | 2019 | |
| Abbvie INC. | $764.31 | 2019-2024 | Orilissa, Lo Loestrin Fe |
| Acessa Health INC. | $742.63 | 2022 | |
| Hologic Sales and Service, LLC | $448.60 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System, Aptima |
| Astellas Pharma US INC | $415.86 | 2022-2025 | Veozah |
| Amgen INC. | $372.53 | 2019-2024 | Evenity, Prolia |
| Mayne Pharma Commercial LLC | $326.35 | 2021-2025 | |
| Organon LLC | $321.76 | 2022-2025 | Nexplanon, Nuvaring |
| Sumitomo Pharma America, INC. | $302.50 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $269.26 | 2021-2022 | |
| Coopersurgical, INC. | $257.03 | 2020-2025 | Paragard T 380a, Wallach Cryosurgical Equipment, Fisherbrand Disposable Liquid Infant Heel Warmer |
| Therapeuticsmd, INC. | $222.06 | 2019-2021 | |
| Pfizer INC. | $207.87 | 2022-2025 | |
| Agile Therapeutics, INC. | $151.84 | 2022-2024 | Twirla |
| Millicent US INC | $151.18 | 2024-2025 | Intrarosa, Femring, Femlyv |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $144.92 | 2019-2024 | Gardasil 9, Gardasil |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $131.42 | 2019-2022 | |
| Roche Diagnostics Corporation | $126.78 | 2019 | |
| Duchesnay USA Incorporated | $112.98 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $106.13 | 2019-2022 | |
| Avion Pharmaceuticals | $63.71 | 2021-2023 | Balcoltra |
| Exeltis, USA INC. | $61.76 | 2025 | Slynd |
| Bard Access Systems, INC. | $46.99 | 2019 | |
| Allergan, INC. | $38.87 | 2019 | |
| Ibsa Pharma INC. | $37.66 | 2023 | Tirosint, Licart |
| Medline Industries LP | $37.33 | 2024 | |
| Vertical Pharmaceuticals, LLC | $36.99 | 2019 | |
| Scynexis, INC. | $33.31 | 2022 | |
| Lupin INC. | $32.16 | 2020 | |
| Boston Scientific Corporation | $31.42 | 2019 | |
| Amag Pharmaceuticals, INC. | $24.22 | 2019 | |
| Dysis Medical, INC. | $23.45 | 2022 | |
| Convatec INC. | $22.00 | 2022 | |
| Pharmacosmos Therapeutics INC. | $20.53 | 2022 | |
| Radius Health, INC. | $20.49 | 2025 | Tymlos |
| Minerva Surgical, INC | $16.42 | 2021 | |
| Ferring Pharmaceuticals INC. | $16.29 | 2019 | |
| Roche Diabetes Care, INC. | $15.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.